IN BRIEF: Oxford BioDynamics inks EpiSwitch kit deal with Agilent

Oxford BioDynamics PLC - biotechnology firm focused on discovery and development of epigenetic ...

Alliance News 31 March, 2021 | 8:18PM
Email Form Facebook Twitter LinkedIn RSS

Oxford BioDynamics PLC - biotechnology firm focused on discovery and development of epigenetic biomarkers - Signs supply and resale agreement with NYSE-listed Agilent Technologies, which operates in life sciences, diagnostics and applied chemical markets.

Under its terms, Agilent will supply a custom-made SurePrint G3 CGH Microarray for Oxford BioDynamics' EpiSwitch Explorer Array kit, which is for 3D genome profiling and biomarker discovery.

OBD meanwhile will have exclusive rights for the kit's supply and distribution.

Current stock price: 101.00 pence

Year-to-date change: up 22%

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Oxford BioDynamics PLC 7.80 GBX -0.64 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures